Cannabis firm Cronos in talks with Marlboro maker Altria about investment

(This story has been up to date to incorporate Cronos’ affirmation of the investment talks.)

Cronos Group – the Ontario, Canada-based hashish multinational – confirmed it’s engaged in discussions with tobacco big Altria Group about a “potential investment” by the corporate that produces Marlboro cigarettes.

The announcement from Cronos got here after Reuters reported that Altria – one of many largest tobacco corporations in North America – is in “early stage talks” to accumulate the marijuana firm.

In its assertion, Cronos “confirmed that it is engaged in discussions concerning a potential investment by Altria Group Inc. … No agreement has been reached with respect to any such transaction and there can be no assurance such discussions will lead to an investment or other transaction involving the companies.”

Altria – proprietor of Marlboro maker Philip Morris USA and an investor in alcohol big Anheuser-Busch InBev – has been assessing market alternatives in the hashish business.

If a deal is accomplished, it might mark the primary vital investment in the hashish sector by a big alcohol or tobacco firm since Constellation Brands purchased a stake in Ontario-based Canopy Growth.

That strategic relationship started in October 2017 and was expanded in August 2018 when Constellation introduced a further investment of 5 billion Canadian dollars ($three.78 billion) in the marijuana firm.

Since then quite a lot of reported negotiations have did not materialize into formal offers, together with Coca-Cola with Alberta-based Aurora Cannabis and Diageo’s discussions with “at least three Canadian cannabis producers.”

Cronos is traded on the Toronto Stock Exchange and the Nasdaq beneath the ticker image CRON.

To join our weekly worldwide marijuana enterprise publication, click on right here.

Categories: Briefs, Canada Marijuana News, Infused Products & Extraction, International Marijuana Business News, United States



Reference

Be the first to comment

Leave a Reply

Your email address will not be published.


*